Named on one round in the feed.
Since 2026-11-13
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Phrontline Biopharma Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies. | Series A Verified against 4 sources | $40M | 2026-11-13 | [ LEAD ] |